Low prevalence of BRCA1 and BRCA2 mutations in the sporadic breast cancer of Spanish population

Familial Cancer

Volumn 11, Issue 1, 2012, Pages 49-56

  De Juan Jiménez, Inmaculada ^a   Esteban Cardeñosa, Eva ^a   Palanca Suela, Sarai ^a   Barragán González, Eva ^a   Aznar Carretero, Ismael ^a   Munárriz Gandía, Blanca ^a   Santaballa Bertran, Ana ^a   Torregrosa Maicas, María Dolores ^b   Guillén Ponce, Carmen ^c   Sánchez Heras, Ana Beatriz ^c   Bayón Lara, Ana ^d   Fuster Lluch, Oscar ^a   Bolufer Gilabert, Pascual ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL LLUÍS ALCANYÍS   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^d Service of Surgery   (Spain)

Author keywords

BRCA1; BRCA2; High resolution melting (HRM); Spanish mutations; Sporadic breast cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; SPAIN; SPORADIC BREAST CANCER;

ADULT; AGED; AGED, 80 AND OVER; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PEDIGREE; SPAIN;

EID: 84858282521     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-011-9481-7     Document Type: Article

References (33)

1. Boyley P, Ferlay J (2004) Cancer incidence and mortality in Europe. Ann Oncol 16:481-488
2. Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71 (Pubitemid 24345325)
3. Wooster R, Bignell G, Lancaster J et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 78:789-792 (Pubitemid 26004412)
4. Ford D, Easton DF, Stratton MR et al (1998) The breast cancer linkage consortium: genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676-689 (Pubitemid 28164626)
5. Balmain A, Gray J, Ponder B (2003) The genetics and genomics of cancer. Nat Genet 33:238-244 (Pubitemid 36278834)
6. Garcia-Patiño E, Gomendio B, Provencio M, Silva JM et al (1998) Germ-line BRCAl mutations in women with sporadic breast cancer: clinical correlations. J Clin Oncol 16:115-120 (Pubitemid 28041587)
7. Seo JH, Cho DY, Ahn SH et al (2004) BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer. Hum Mutat 24:350
8. Han SH, Lee KR, Lee DG et al (2006) Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer. Clin Genet 70:496-501
9. Neuhausen SL (1999) Ethnic differences in cancer risk resulting from genetic variation. Cancer 86:2575-2582
10. Martínez-Ferrandis JI, Vega A, Chirivella I et al (2003) Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations. Hum Mutat 22:417-418
11. Diez O, Osorio A, Duran M et al (2003) Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat 22:301-312 (Pubitemid 37210855)
12. Esteban E, Bolufer P, de Juan I et al (2010) Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population. Breast Cancer Res Treat 121:257-260
13. Esteban E, Bolufer P, Palanca S et al (2008) Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain. Breast Cancer Res Treat 112: 69-73
14. Infante M, Durán M, Esteban-Cardeñosa E, Miner C, Velasco E (2006) High proportion of novel mutations of BRCA1 and BRCA2 in breast/ovarian cancer patients from Castilla-León (central Spain). J Hum Genet 51:611-617 (Pubitemid 44048694)
15. Salazar R, Cruz-Hernandez JJ, Sanchez-Valdivieso E et al (2006) BRCA1-2 mutations in breast cancer: identification of nine new variants of BRCA1-2 genes in a population from central Western Spain. Cancer Lett 233:172-177 (Pubitemid 43214576)
16. Bolufer P, Munárriz B, Santaballa A et al (2005) Mutaciones en BRCA1 y BRCA2 en pacientes con historia familiar de cáncer de mama. Med Clin (Barc) 124:10-12 (Pubitemid 40208965)
17. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects (ver.2004): [http://www.wma.net/e/ policy/pdf/17c.pdf]
18. de Juan I, Esteban E, Palanca S, Barragán E, Bolufer P (2009) High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations. Breast Cancer Res Treat 115: 405-414
19. de Juan I, Esteban E, Palanca S et al (2011) Advantage of highresolution melting curve analysis over conformation-sensitive gel electrophoresis for mutational screening of BRCA1 and BRCA2 genes. Clin Chim Acta 412:578-582
20. Esteban-Cardeñosa E, Durán M, Infante M, Velasco E, Miner C (2004) A high-throughput mutation detection method to scan BRCA1 and BRCA2 based on heteroduplex analysis by capillary array electrophoresis. Clin Chem 50:313-320
21. den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7-12
22. Berkeley Drosophila Genome Project: [http://www.fruitfly.org/seq-tools/ splice.html]
23. ESEfinder: [http://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi? process=home]]
24. ESRsearch: [http://esrsearch.tau.ac.il/]
25. RESCUE-ESE: [http://genes.mit.edu/burgela/rescue-ese/]
26. Phelan CM, Dapic V, Tice B et al (2005) Classification of BRCA1 missense variants of unknown clinical significance. J Med Genet 42:138-146
27. Malone KE, Daling JR, Thompson JD et al (1998) BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA 279:922
28. De la Hoya M, Osorio A, Godino J et al (2002) Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing. Int J Cancer 97:466-471 (Pubitemid 34027805)
29. Newman B, Mu H, Butler LM et al (1998) Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 279:915-921 (Pubitemid 28136080)
30. Osorio A, De La Hoya M, Rodriguez-Lopez R et al (2002) Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer 99:305-309 (Pubitemid 34309491)
31. Venkitaraman AR (2009) Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu Rev Pathol Mech Dis 4:461-487
32. Palacios J, Robles-Frías MJ, Castilla MA, López- García MA, Benítez J (2008) The molecular pathology of hereditary breast cancer. Pathobiology 75:85-94 (Pubitemid 351820726)
33. Bosch A, Eroles P, Zaragoza R, Viña JR, Lluch A (2010) Triplenegative breast cancer: molecular features, pathogenesis, treatment and current lines of research. Cancer Treat Rev 36:206-215